期刊文献+

髂内动脉化疗联合膀胱局部灌注治疗中晚期膀胱癌 被引量:1

Treatment for middle and advanced stage of bladder cancer through intra-internal iliac artery infusion chemotherapy
下载PDF
导出
摘要 目的:探讨术后髂内动脉介入灌注及栓塞在治疗中晚期浸润性膀胱癌的疗效。方法:对我院1995年1月~2006年1月32例膀胱部分切除术后,髂内动脉灌注及栓塞联合膀胱灌注化疗治疗的中晚期膀胱癌患者的临床资料进行回顾性分析。结果:32例患者5年生存率为80.77%。术后2年内无因肿瘤进展死亡,仅肿瘤局部复发3例。至随访截止日期,死于术后肿瘤进展共6例。结论:髂内动脉化疗栓塞是中晚期膀胱癌膀胱部分切除术后的一种有效的辅助治疗方法,能明显提高患者的5年生存率。 Objective:To study the clinical effects of intra-internal iliac arterial infusion chemotherapy and embolization for middle and advanced stage of bladder cancer after the operation. Methods :The clinical data of 32 cases of partial cysteetomy combined with intra-internal iliac arterial infusion chemotherapy and embolization after the operation were retrospectively analyzed in our hospital fi'om 1995 to 2006. Results : All the 32 cases were followed up for 2 to 6 years. No patient died of tumor progression in 2 years after the operation(0/32). The 5-year survival rate for this group patients was 80. 77% (21/26). Tumor partly recurrence happened in 3 cases in 2 years after the operation. Till cut-off date, there were 6 cases died of tumor progression after the operation. Conclusion :Intra-internal iliac arterial infusion chemotherapy and embolization might be served as an adjuvant therapy for middle and advanced stage of bladder cancer after partial cystectomy. This method can reserve bladder function, which is an effective therapeutic method for patients with middle and advanced stage of bladder cancer, and the 5-year survival rate of bladdercancer could be further improved.
出处 《临床肿瘤学杂志》 CAS 2008年第9期825-827,共3页 Chinese Clinical Oncology
关键词 膀胱癌 介入放射学 髂内动脉灌注 化学治疗 Bladder tumor Interventional radiology Intra-internal iliac arterial infusion Chemotherapy
  • 相关文献

参考文献6

二级参考文献28

  • 1李鸣,李宁忱,黄真,那彦群.浸润性膀胱癌术前选择性髂内动脉灌注化疗的近远期疗效观察[J].中华泌尿外科杂志,2004,25(10):662-664. 被引量:20
  • 2王艳,孙建国,叶明福,陈正堂.Podoplanin阳性淋巴管密度与非小细胞肺癌预后的关系[J].中华结核和呼吸杂志,2006,29(11):758-761. 被引量:8
  • 3顾方六.尿路上皮肿瘤临床[A].吴阶平 主编.泌尿外科:第2版[C].济南:山东科学技术出版社,1997.453-475.
  • 4Tsukamoto S, Ishikawa S, Tsutsumi M, et al. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma. Scand J U rol Nephrol,2002,36:339-343.
  • 5Rodel C, Grabenbauer GG, Kuhn R, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer:long-term results. J Clin Oncol,2002,20: 3061-3071.
  • 6Hayashi N,Arima K, Kawamura J,et al. Preoperative balloon occluded arterial infusion chemotherapy for locally invasive bladder cancer-accurate staging for bladder preservation. Hinyokika Kiyo, 1999,45:139-143.
  • 7Startsev VY. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences. Arch Ital Urol Androl,2002,74:54-56.
  • 8Kobayashi M,Sugaya Y,Yuzawa M,et al. Intra-arterial infusion chemotherapy for superficial bladder cancer. Hinyokika Kiyo, 1999,45:605 -607.
  • 9Oosterlinck W,Lobel B,Jakse G,et al. Guidelines on bladder cancer. Eur Urol, 2002,41:105-112.
  • 10Lamm DL,Blumenstein BA, Crissman JD,et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA,T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol,2000,163:1124-1129.

共引文献35

同被引文献14

  • 1吴忠标,林国兵,陈柏君,吴忠明,戎瑞明.不同剂量表柔比星膀胱灌注预防浅表性膀胱癌复发的疗效与安全性[J].中华肿瘤杂志,2005,27(8):507-509. 被引量:17
  • 2兰卫华,靳风烁,王洛夫,谢芳,王晶.卡介苗与丝裂霉素C膀胱灌注预防浅表性膀胱癌复发疗效及毒性比较的Meta分析[J].中华泌尿外科杂志,2006,27(1):29-32. 被引量:36
  • 3Sharma S, Ksheersagar P, Sharma P. Diagnosis and treatment ofbladder cancer [J]. Am Fam Physician, 2009,80(7) :717-723.
  • 4van der Heijden AG, Witjes JA. Intravesical chemotherapy: anupdate-new trends and perspectives [J]. EAU Update Series,2003,1(3):71-79.
  • 5DrSgoescu 0,Tomescu P, P5nu SA, et al. Adjuvant treatmentof intermediate risk non-muscle invasive bladder cancer [J]. CurrHealth Sci J, 2014,40(1):47.
  • 6Wirth M, Plattner VE, Gabor F. Strategies to improve drugdelivery in bladder cancer therapy [J]. Expert Opin Drug Deliv,2009,6(7):727-744.
  • 7Kobayashi M, Sugaya Y, Yuzawa M, et al. Appropriateintravesical retention time of pirarubicin concentration based on itslevel in tumor tissue, anti-tumor effect and side effect inintravesical instillation therapy for bladder tumor [J]. Gan ToKagaku Ryoho, 1998,25(11): 1771-1774.
  • 8Kobayashi M , Sugaya Y, Yuzawa M. Intra-arterial infusionchemotherapy for superficial bladder cancer [J]. Hinyokika Kiyo,1999,45(9):605-607.
  • 9Mokarim A, Uetani M,Nayashi N, et al. Combined intraarterialchemotherapy and radiotherapy in the treatment of bladdercarcinoma [J]. Cancer, 1997,80(9) : 1776-1785.
  • 10Chen MK, Qin ZK, Zhou FJ, et al. Intra-arterial chemotherapyis reliable in preventing high-risk superficial bladder cancer fromrecurrence and progression [J]. J Chemother, 2009,21 (6):681-686.

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部